Teva plant tagged with warning letter for issues making schizophrenia drug | Fierce Pharma
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva months from restarting production at Hungary plant banned by US FDA
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva expects FDA preapproval inspection of troubled Celltrion plant this year | Fierce Pharma
Troubled Teva plant in Hungary faces an FDA crackdown - STAT
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
Teva Recalls U.S.-Made Drugs Following Contamination Fears | 2021-10-04 | SupplyChainBrain
Site Inspections | Teva api
After Ignoring Letters From US FDA, Teva And Cipla Will Have ANDAs Withdrawn :: Pink Sheet
FDA Warns Teva API Plant in China | RAPS
Amicus Therapeutics: Finally The FDA Inspection Is Done (NASDAQ:FOLD) | Seeking Alpha
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva Recalls One Lot Of IDArubicin Hydrochloride Injection
FDA Scorecard: Drug Shortages and Inspections - DCAT Value Chain Insights
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva Stops Production At US Plant After FDA Concerns: Report
Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin Hydrochloride Injection USP 5 mg/5 mL Due to the Presence of Particulate Matter | FDA
Teva confirms US FDA warning letter for Hangzhou, China API plant
Teva recalls US-made drugs following contamination fears - The Boston Globe
Teva stock drops on guidance, manufacturing problems - MarketWatch
Teva Pharmaceutical Works Private Limited Company 10/13/16
FDA warning letter says Teva China plant has more work to do on API issues | Fierce Pharma
Celltrion FDA warning causes headache for Teva's biologics ambition
FDA to share full inspection reports with EU; Difficult week for Teva, J&J, Mylan | Radio Compass Blog
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
